Completed Cells, Biochemistry & Physiology Genetics & Molecular Biology

Core Funding for the Wellcome Trust Centre for Cell Biology

In plain English

AI plain-English summary

Every human cell packs two metres of DNA into a nucleus a few millionths of a metre across, and the Wellcome Trust Centre for Cell Biology wants to understand exactly how that packaging controls which genes are switched on or off. This matters because many common diseases—including cancers, developmental disorders, and autoimmune conditions—involve errors in these packaging and switching mechanisms, known as epigenetic processes. Current genomic studies reveal that these errors are important, but scientists still do not understand the basic machinery behind them. The Centre will combine genetics, biochemistry, imaging, and mathematical modelling to answer four core questions: whether epigenetic changes cause or merely reflect gene expression shifts, what long non-coding RNAs do in regulation, how genetic information is faithfully copied during cell division, and how changes in chromatin structure link to specific human diseases. This is fundamental science. It will not produce a drug or a diagnostic test in the short term. But a mechanistic understanding of how cells organise and transmit their genetic information has historically underpinned breakthroughs in cancer therapy, regenerative medicine, and prenatal screening. Deeper knowledge of these processes could eventually open routes to treatments for conditions where the underlying biology is now opaque.

View original technical description
The Wellcome Trust Centre for Cell Biology (WTCCB) is internationally renowned for its outstanding group leaders and research achievements in understanding the function and replication of eukaryotic cells. Genomic analyses of complex human diseases demonstrate both the importance of epigenetic processes and our limited mechanistic understanding. We therefore propose to focus on understanding key epigenetic mechanisms, bringing together the major themes of nuclear organisation, genome packaging and transmission, chromatin states and RNA biology. We will chart key interconnections between these processes, identifying mechanisms and regulation. WTCCB will combine genetics, biochemistry, genomics, mathematical modelling, imaging, synthetic biology and single cell analyses to address key questions: 1) Do epigenetic mechanisms drive or reflect changes in gene expression, in response to the environment, development and disease? 2) What are the functions of lncRNAs and other RNAs in regulating gene expression? 3) How is the genetic information faithfully transmitted during mitosis and meiosis? 4) How are changes in the structure of chromatin and other complexes linked to specific human diseases? To enhance the medical impact of our research, WTCCB will forge strategic alliances with experts in medical genetics. We will generate insights into mechanisms underlying human pathologies, potentially opening routes to longer-term therapeutic solutions.

View the original record at the funder ↗

Researchers

David Tollervey (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Core funding renewal for the Wellcome Trust Centre for Cell Biology .
Dynamic Cell Biology
Dynamic Molecular Cell Biology
BBSRC Institute Strategic Programme: Cellular Genomics (CELLGEN) - Partner Grant
Understanding how Trithorax & Polycomb group proteins control gene expression from CpG islands

Original classification

Wellcome Trust Centre

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.